Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ishigami

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Investigation|April 1, 1997
High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteinsM Ishigami, S Yamashita, N Sakai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1997
Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevityK Hirano, S Yamashita, N Nakajima, et al.
Hepatology (Baltimore, Md.)|June 1, 1997
Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis CE Shinohara, S Yamashita, S Kihara, et al.
The Journal of Clinical Investigation|October 1, 1995
Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjectsS Nozaki, H Kashiwagi, S Yamashita, et al.
Atherosclerosis|April 1, 1993
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemiaK Hirano, S Yamashita, T Funahashi, et al.
European Journal of Clinical Investigation|March 19, 2003
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosisY Saika, N Sakai, M Takahashi, et al.
Journal of Viral Hepatitis|April 7, 2010
Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapyK Hayashi, Y Katano, M Ishigami, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2016
Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological responseY Tachi, T Hirai, Y Kojima, et al.
Paediatrics and International Child Health|May 6, 2015
Impact of an Emergency Triage Assessment and Treatment (ETAT)-based triage process in the paediatric emergency department of a Guatemalan public hospitalHeather L Crouse, Francisco Torres, Henry Vaides, et al.
European Journal of Clinical Investigation|June 4, 2009
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemiaD Masuda, Y Nakagawa-Toyama, K Nakatani, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Investigation|April 1, 1997
High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteinsM Ishigami, S Yamashita, N Sakai, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 1997
Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevityK Hirano, S Yamashita, N Nakajima, et al.
Hepatology (Baltimore, Md.)|June 1, 1997
Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis CE Shinohara, S Yamashita, S Kihara, et al.
The Journal of Clinical Investigation|October 1, 1995
Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjectsS Nozaki, H Kashiwagi, S Yamashita, et al.
Atherosclerosis|April 1, 1993
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemiaK Hirano, S Yamashita, T Funahashi, et al.
European Journal of Clinical Investigation|March 19, 2003
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosisY Saika, N Sakai, M Takahashi, et al.
Journal of Viral Hepatitis|April 7, 2010
Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapyK Hayashi, Y Katano, M Ishigami, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2016
Liver stiffness measurement using acoustic radiation force impulse elastography in hepatitis C virus-infected patients with a sustained virological responseY Tachi, T Hirai, Y Kojima, et al.
Paediatrics and International Child Health|May 6, 2015
Impact of an Emergency Triage Assessment and Treatment (ETAT)-based triage process in the paediatric emergency department of a Guatemalan public hospitalHeather L Crouse, Francisco Torres, Henry Vaides, et al.
European Journal of Clinical Investigation|June 4, 2009
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemiaD Masuda, Y Nakagawa-Toyama, K Nakatani, et al.
Pageof 10